These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23666671)

  • 1. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.
    Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor.
    Chakraborty A; Pasek DA; Huang TQ; Gomez AC; Yamaguchi N; Anderson ME; Meissner G
    PLoS One; 2014; 9(8):e104338. PubMed ID: 25093823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel.
    Yamaguchi N; Takahashi N; Xu L; Smithies O; Meissner G
    J Clin Invest; 2007 May; 117(5):1344-53. PubMed ID: 17431507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac calcium signalling pathologies associated with defective calmodulin regulation of type 2 ryanodine receptor.
    Arnáiz-Cot JJ; Damon BJ; Zhang XH; Cleemann L; Yamaguchi N; Meissner G; Morad M
    J Physiol; 2013 Sep; 591(17):4287-99. PubMed ID: 23836685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.
    Yamaguchi N; Prosser BL; Ghassemi F; Xu L; Pasek DA; Eu JP; Hernández-Ochoa EO; Cannon BR; Wilder PT; Lovering RM; Weber D; Melzer W; Schneider MF; Meissner G
    Am J Physiol Cell Physiol; 2011 May; 300(5):C998-C1012. PubMed ID: 21289290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A1 Protein Does Not Compete with Calmodulin for Ryanodine Receptor Binding but Structurally Alters the Ryanodine Receptor·Calmodulin Complex.
    Rebbeck RT; Nitu FR; Rohde D; Most P; Bers DM; Thomas DD; Cornea RL
    J Biol Chem; 2016 Jul; 291(30):15896-907. PubMed ID: 27226555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor).
    Yamaguchi N; Xu L; Pasek DA; Evans KE; Meissner G
    J Biol Chem; 2003 Jun; 278(26):23480-6. PubMed ID: 12707260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.
    Søndergaard MT; Liu Y; Larsen KT; Nani A; Tian X; Holt C; Wang R; Wimmer R; Van Petegem F; Fill M; Chen SR; Overgaard MT
    J Biol Chem; 2017 Jan; 292(4):1385-1395. PubMed ID: 27927985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A1 and calmodulin compete for the same binding site on ryanodine receptor.
    Wright NT; Prosser BL; Varney KM; Zimmer DB; Schneider MF; Weber DJ
    J Biol Chem; 2008 Sep; 283(39):26676-83. PubMed ID: 18650434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ca
    Wei J; Yao J; Belke D; Guo W; Zhong X; Sun B; Wang R; Paul Estillore J; Vallmitjana A; Benitez R; Hove-Madsen L; Alvarez-Lacalle E; Echebarria B; Chen SRW
    Circ Res; 2021 Feb; 128(4):e63-e83. PubMed ID: 33375811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.
    Ritterhoff J; Völkers M; Seitz A; Spaich K; Gao E; Peppel K; Pleger ST; Zimmermann WH; Friedrich O; Fink RHA; Koch WJ; Katus HA; Most P
    Mol Ther; 2015 Aug; 23(8):1320-1330. PubMed ID: 26005840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different regions in skeletal and cardiac muscle ryanodine receptors are involved in transducing the functional effects of calmodulin.
    Yamaguchi N; Xu L; Evans KE; Pasek DA; Meissner G
    J Biol Chem; 2004 Aug; 279(35):36433-9. PubMed ID: 15215235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyad content is reduced in cardiac myocytes of mice with impaired calmodulin regulation of RyR2.
    Lavorato M; Huang TQ; Iyer VR; Perni S; Meissner G; Franzini-Armstrong C
    J Muscle Res Cell Motil; 2015 Apr; 36(2):205-14. PubMed ID: 25694159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin modulates the termination threshold for cardiac ryanodine receptor-mediated Ca2+ release.
    Tian X; Tang Y; Liu Y; Wang R; Chen SR
    Biochem J; 2013 Nov; 455(3):367-75. PubMed ID: 23992453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling.
    Kohno M; Kobayashi S; Yamamoto T; Yoshitomi R; Kajii T; Fujii S; Nakamura Y; Kato T; Uchinoumi H; Oda T; Okuda S; Watanabe K; Mizukami Y; Yano M
    Commun Biol; 2020 Nov; 3(1):714. PubMed ID: 33244105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of S100A1 expression leads to Ca
    Hernández-Ochoa EO; Melville Z; Vanegas C; Varney KM; Wilder PT; Melzer W; Weber DJ; Schneider MF
    Physiol Rep; 2018 Aug; 6(15):e13822. PubMed ID: 30101473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two EF-hand motifs in ryanodine receptor calcium release channels contribute to isoform-specific regulation by calmodulin.
    Xu L; Gomez AC; Pasek DA; Meissner G; Yamaguchi N
    Cell Calcium; 2017 Sep; 66():62-70. PubMed ID: 28807150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of impaired calmodulin binding to RyR2 as a novel therapy for lethal arrhythmia in the pressure-overloaded heart failure.
    Kato T; Yamamoto T; Nakamura Y; Nanno T; Fukui G; Sufu Y; Hamada Y; Maeda T; Nishimura S; Ishiguchi H; Murakami W; Fukuda M; Xu X; Hino A; Ono M; Oda T; Okuda S; Kobayashi S; Koseki N; Kyushiki H; Yano M
    Heart Rhythm; 2017 Jan; 14(1):120-127. PubMed ID: 27771553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A1's single cysteine is an indispensable redox switch for the protection against diastolic calcium waves in cardiomyocytes.
    Seitz A; Busch M; Kroemer J; Schneider A; Simon S; Jungmann A; Katus HA; Most P; Ritterhoff J
    Am J Physiol Heart Circ Physiol; 2024 Jul; 327(1):H000. PubMed ID: 38819384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.